Thyroid Cancer Database

NCT ID: NCT04031638

Last Updated: 2019-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-01

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thyroid cancer database collects clinical and laboratory data from patients with a thyroid tumor who received radioactive Iodine treatment. This database only records information based on patients' medical files in a structured manner.

Thyroid database is used for retrospective non-interventional research projects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients With a Thyroid Tumor Who Received Radioactive Iodine Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radioactive Iodine treatment for thyroid cancer

Radioactive Iodine treatment

Intervention Type OTHER

Patients with a thyroid tumor who received radioactive Iodine treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radioactive Iodine treatment

Patients with a thyroid tumor who received radioactive Iodine treatment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with a thyroid tumor (metastatic or not)
* patients who received radioactive Iodine treatment.
* age \>= 18

Exclusion Criteria

* Objection to collect medical data records
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Georges Francois Leclerc

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Methodology, Biostatistics and Data Management

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

AURELIE BERTAUT, MD, PhD

Role: CONTACT

+33 3 80 73 77 84

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

AURELIE BERTAUT, MD, PhD

Role: primary

+33 3 80 73 77 84

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AB2015THYROID

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Studies on Tumors of the Thyroid
NCT00001160 RECRUITING
Hyperthyroid Follow-Up Study
NCT02989103 COMPLETED